OMGA Earnings & Forecasts - Benzinga

SPY768.41+0.58%QQQ748.11+0.82%BTC/USD84,516.80−0.40%DIA510.06+0.28%GLD378.70−1.06%TLT77.34−0.48%

OMGA

OMGANasdaq Private Market

Private market price is not available

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

OMGA Earnings & Forecasts - Benzinga

OMGA Earnings & Forecasts

OMGA (OMGA) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

OMGA Guidance

Recent Earnings Results

Metric	Q3 '24	Q2 '24	Q1 '24	Q4 '23
Earnings Per Share (Non-GAAP)
Estimate	$-0.28	$-0.36	$-0.33	$-0.45
Actual	$-0.30	$-0.30	$-0.36	$-0.37
Surprise	-7.14%	+16.7%	-9.09%	+17.8%
Revenue
Estimate	$1.2M	$950000	$1.6M	$570000
Actual	$2.6M	$2.1M	$2.4M	$989000
Surprise	+110.7%	+124.6%	+44.8%	+73.5%

Earnings & Guidance News

US Stocks Mixed; PepsiCo Posts Downbeat Sales

Avi Kapoor

PRO
Omega Therapeutics Q3 2024 GAAP EPS $(0.30) Misses $(0.28) Estimate, Sales $2.612M Beat $1.240M Estimate

Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.28) by 7.14 percent. The company reported quarterly sales of $2.612 million which beat

Benzinga Newsdesk

Omega Therapeutics, Inc. Reports Q1 Loss, Tops Revenue Estimates

Omega Therapeutics, Inc. (NASDAQ: OMGA) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $0.50 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

PRO
Omega Therapeutics Q1 2024 GAAP EPS $(0.36) Misses $(0.35) Estimate, Sales $2.360M Beat $1.630M Estimate

Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.35) by 2.86 percent. The company reported quarterly sales of $2.360 million which beat

Benzinga Newsdesk

PRO
Omega Therapeutics Q4 2023 GAAP EPS $(0.37) Beats $(0.47) Estimate

Omega Therapeutics (NASDAQ:OMGA) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.47) by 21.28 percent.

Benzinga Newsdesk

Dow Surges 200 Points; US Services PMI Edges Higher In December

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 200 points on Thursday. The Dow traded up 0.55% to 37,635.05 while the NASDAQ rose 0.05% to 14,599.10. The S&P 500 also rose, gaining, 0.28% to 4,718.19.

Avi Kapoor

Quarterly Earnings Surprise Amount

Fiscal Quarter	Date Reported	Actual EPS	Estimated EPS	Surprise %
Q3	Nov 14, 2024	$-0.30	$-0.28	-7.14 %
Q2	Aug 6, 2024	$-0.30	$-0.36	16.7 %
Q1	May 6, 2024	$-0.36	$-0.33	-9.09 %
Q4	Mar 28, 2024	$-0.37	$-0.45	17.8 %

Quarterly Revenue Surprise Amount

Fiscal Quarter	Date Reported	Actual Revenue	Estimated Revenue	Surprise %
Q3	Nov 14, 2024	$2.61M	$1.24M	110.7 %
Q2	Aug 6, 2024	$2.13M	$950.00K	124.6 %
Q1	May 6, 2024	$2.36M	$1.63M	44.8 %
Q4	Mar 28, 2024	$989.00K	$570.00K	73.5 %